JP2004524279A5 - - Google Patents

Download PDF

Info

Publication number
JP2004524279A5
JP2004524279A5 JP2002541086A JP2002541086A JP2004524279A5 JP 2004524279 A5 JP2004524279 A5 JP 2004524279A5 JP 2002541086 A JP2002541086 A JP 2002541086A JP 2002541086 A JP2002541086 A JP 2002541086A JP 2004524279 A5 JP2004524279 A5 JP 2004524279A5
Authority
JP
Japan
Prior art keywords
compound
methyl
formula
vinyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002541086A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004524279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/012818 external-priority patent/WO2002038551A1/en
Publication of JP2004524279A publication Critical patent/JP2004524279A/ja
Publication of JP2004524279A5 publication Critical patent/JP2004524279A5/ja
Pending legal-status Critical Current

Links

JP2002541086A 2000-11-10 2001-11-06 ピリミジン誘導体、及びニューロペプチドy受容体リガンドとしてのその使用 Pending JP2004524279A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124610 2000-11-10
PCT/EP2001/012818 WO2002038551A1 (en) 2000-11-10 2001-11-06 Pyrimidine derivatives and their use as neuropeptide y receptor ligands

Publications (2)

Publication Number Publication Date
JP2004524279A JP2004524279A (ja) 2004-08-12
JP2004524279A5 true JP2004524279A5 (enExample) 2005-04-21

Family

ID=8170342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002541086A Pending JP2004524279A (ja) 2000-11-10 2001-11-06 ピリミジン誘導体、及びニューロペプチドy受容体リガンドとしてのその使用

Country Status (20)

Country Link
US (1) US6657060B2 (enExample)
EP (1) EP1335906B1 (enExample)
JP (1) JP2004524279A (enExample)
KR (1) KR100611853B1 (enExample)
CN (1) CN1473156A (enExample)
AR (1) AR034700A1 (enExample)
AT (1) ATE340784T1 (enExample)
AU (2) AU2790502A (enExample)
BR (1) BR0115045A (enExample)
CA (1) CA2427350A1 (enExample)
DE (1) DE60123458T2 (enExample)
DK (1) DK1335906T3 (enExample)
ES (1) ES2271100T3 (enExample)
MX (1) MXPA03004136A (enExample)
PA (1) PA8531701A1 (enExample)
PE (1) PE20020603A1 (enExample)
PT (1) PT1335906E (enExample)
UY (1) UY27018A1 (enExample)
WO (1) WO2002038551A1 (enExample)
ZA (1) ZA200302970B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3813152B2 (ja) 2002-03-12 2006-08-23 メルク エンド カムパニー インコーポレーテッド 置換アミド類
EP1484971B1 (en) * 2002-03-15 2007-07-04 Ciba SC Holding AG Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
US7768604B2 (en) * 2005-09-20 2010-08-03 Au Optronics Corporation Transflective liquid crystal display with partially shifted reflectivity curve
KR20080083188A (ko) * 2006-01-11 2008-09-16 아스트라제네카 아베 모르폴리노 피리미딘 유도체 및 요법에서의 그 유도체의용도
GB0616747D0 (en) * 2006-08-24 2006-10-04 Astrazeneca Ab Novel compounds
EP2057129A1 (en) * 2006-08-24 2009-05-13 AstraZeneca AB Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
AU2007287428B2 (en) * 2006-08-24 2011-08-11 Astrazeneca Ab Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
CA2692720A1 (en) 2007-07-09 2009-01-15 Astrazeneca Ab Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
EP2178866A2 (en) * 2007-07-09 2010-04-28 AstraZeneca AB Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
EA201000092A1 (ru) * 2007-07-09 2010-06-30 Астразенека Аб Тризамещенные пиримидиновые производные для лечения пролиферативных заболеваний
AU2008273892A1 (en) * 2007-07-09 2009-01-15 Astrazeneca Ab Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
WO2010030027A1 (en) 2008-09-10 2010-03-18 Mitsubishi Tanabe Pharma Corporation Aromatic nitrogen-containing 6-membered ring compounds and their use
US20110053923A1 (en) * 2008-12-22 2011-03-03 Astrazeneca Chemical compounds 610
JP2011201873A (ja) * 2010-03-03 2011-10-13 Mitsubishi Tanabe Pharma Corp 三置換ピリミジン化合物及びそのpde10阻害薬としての使用
EP2544690A4 (en) * 2010-03-11 2013-07-10 Targacept Inc ARYLVINYLAZACYCLOALCANE COMPOUNDS FOR CONSTIPATION
SA111320519B1 (ar) 2010-06-11 2014-07-02 Astrazeneca Ab مركبات بيريميدينيل للاستخدام كمثبطات atr
WO2015039292A1 (zh) * 2013-09-18 2015-03-26 华安医学股份有限公司 一种活化ampk的化合物及其用途
CN112375042A (zh) * 2020-10-27 2021-02-19 安徽医科大学 三甲氧基苯乙烯基六元环类和吡唑并嘧啶类化合物、制剂及其制备与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720467B2 (ja) * 1988-06-15 1995-03-08 松下電器産業株式会社 超音波診断装置
JPH024345A (ja) * 1988-06-15 1990-01-09 Matsushita Electric Ind Co Ltd 超音波変換装置
JP2789134B2 (ja) 1992-09-28 1998-08-20 ファイザー・インク. 糖尿病の合併症を制御する置換ピリミジン類
US6011039A (en) 1996-03-21 2000-01-04 Banyu Pharmaceutical Co., Ltd. Aminopyridine derivatives
WO1998040356A1 (en) * 1997-03-12 1998-09-17 Banyu Pharmaceutical Co., Ltd. Drugs containing aminopyridine derivatives as the active ingredient

Similar Documents

Publication Publication Date Title
JP2004524279A5 (enExample)
RU2586974C2 (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
JP2011502958A5 (enExample)
JP2004536066A5 (enExample)
RU2205827C2 (ru) Производное ацилпиперазинилпиримидина, способы его получения, фармацевтическая композиция
JP2005508923A5 (enExample)
JP2012501312A5 (enExample)
NZ604004A (en) Pyridone and aza-pyridone compounds and methods of use
JP2009542638A5 (enExample)
JP2020516671A5 (enExample)
JP2005538955A5 (enExample)
JP2010508338A5 (enExample)
JP2009534386A5 (enExample)
JP2005519908A5 (enExample)
JP2009541268A5 (enExample)
JP2008513514A5 (enExample)
CA2258728A1 (en) Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US20130324551A1 (en) Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors
JP2007508346A5 (enExample)
JP2007523182A5 (enExample)
JP2009504792A5 (enExample)
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2008141509A (ru) Mglur5 модуляторы 1
JP2005523901A5 (enExample)
JP2020500192A5 (enExample)